Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intralesional or Intramuscular Hepatitis B Vaccine Versus Intralesional Saline in the Treatment of Multiple Common Warts

NCT05326152 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT05326152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05326152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intralesional or Intramuscular Hepatitis B Vaccine Versus Intralesional Saline in the Treatment of Multiple Common Warts
Lead sponsor
Zagazig University
Phase
Phase 1/2
Overall status
Completed
Start date
November 25, 2020
Completion date
October 25, 2021
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intralesional versus intramuscular hepatitis b vaccine for multiple common warts